A Pill Makes Pancreatic Cancer Undetectable in One in 12 Patients

Pill to treat pancreatic cancer hailed as 'biggest breakthrough in decades'

A Pill Makes Pancreatic Cancer Undetectable in One in 12 Patients

In a trial of 61 people with advanced pancreatic cancer that had spread, the drug daraxonrasib stopped tumor growth in nearly all of them, shrank or erased tumors in just over 60%, and made the cancer undetectable on scans in about 8%. A year after starting treatment, 76.6% were alive, versus the usual 40-45% on chemotherapy alone. Doctors stop short of calling it a cure, but the KRAS inhibitor could buy patients precious time — and may work against other cancers with similar mutations.

Just imagine, in an average of 18 months your disease just disappears on the CT scan … that's closest to complete remission … it's incredible.

More from this day

2026-11-21